Release of Anticancer Drug Doxorubicin from Biodegradable Polymer Coated Porous Hydroxyapatite Scaffolds

Abstract:

In the current research slow release anticancer drug delivery system was prepared and drug release kinetics in vitro evaluated. Porous hydroxyapatite (HAp) as carrier material and doxorubicin hydrochloride (DOX) as anticancer agent was used. DOX is an anthracycline drug commonly used in cancer chemotherapy. Unfortunately, its therapeutic potential is restricted cardiotoxicity and resistance developed by the tumor cells to the molecule after treatment. To prepare HAp-DOC composites, the porous bioceramic scaffolds were impregnated with doxorubicin in low vacuum conditions. 10% (HAp-10%PLA) and 20% (HAp-20%PLA) poly lactic acid and 20% (HAp-20%PCL) poly(e-caprolactone) solutions in dichloromethane were used to form the polymer coatings on the drug/bioceramic composites. In general there was a burst release observed from all the samples during the first 2 hours followed by a much reduced release profile. In the next 5 days the drug release from all the samples decreased in the following order: 20% PLA (from 56 ng/ml to 3 ng/ml), 20% PCL (from 196 ng/ml to 6 ng/ml), 10% PLA (from 497 ng/ml to 18 ng/ml). HAp-DOX composite without the polymer coating demonstrated the drug release reduction from 230 ng/ml to 13 ng/ml. The cumulative drug release was observed over 19 days.

• Periodical: Advanced Materials Research (Volumes 284-286)
• Pages: 1770-1773
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.284-286.1770
• Online since: July 2011
• Authors: Juris Pelss, Dagnija Loca, Liga Berzina-Cimdina, Janis Locs, Vitalijs Lakevics
• Keywords: Doxorubicin, Drug Release, Hydroxyapatite (HAP), Poly(lactic acid) (PLA), Polycaprolactone (PCL)

References

[1] M. Itokazu, M. Esaki, K. Yamamoto, T. Tanemori, T. Kasai: Local drug delivery system using ceramics: vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block, Journal of Materials Science: Materials in Medecine Vol. 10, 4, p.249.

DOI: 10.1023/a:1008966314075

[2] HT. Ta, CR. Dass, I. Larson, PF. Choong, DE. Dunstan: A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy, Biomaterials, 2009, Sep.30, 27, 2009, p.4815.

DOI: 10.1016/j.biomaterials.2009.05.035

[3] A. Uchida, Y. Shinto, N. Araki, K. Ono: Slow release af Anticancer drugs from porous calcium hydroxyapatite ceramic, Journal of Orthopaedic Research, Vol. 10, 1992, p.440.

DOI: 10.1002/jor.1100100317

[4] XB. Xiong, Z. Ma, R. Lai, A. Lavasanifar: The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin, Biomaterials, 2010, Feb.30, 4, p.757.

DOI: 10.1016/j.biomaterials.2009.09.080

[5] ML. Tan, AM. Friedhuber, DE. Dunstan, PFM. Choong, CR. Dass: The performance of doxorubicin encapsulated in chitosan–dextran sulphate microparticles in an osteosarcoma model, Biomaterials, 2010, Vol.31, 3, p.541.

DOI: 10.1016/j.biomaterials.2009.09.069

[6] A. Talal, N. Waheed, M. Al-Masri, IJ. McKay, KE. Tanner, FJ. Hughes: Adsorption and release of protein from hydroxyapatite-polylactic acid (HA-PLA) membranes, J Dent, Vol. 37 (11), p.820.

DOI: 10.1016/j.jdent.2009.06.014

[7] Y. Ikada, S. Hyon, K. Jamshidi, S. Higashi, T. Yamammuro, Y. Katatani, T. Kitsugi: Release of antibiotic from composites of hydroxyapatite and poly (lactic acid), Journal of Controlled Release, Vol. 2, November, 1985, p.179.

DOI: 10.1016/0168-3659(85)90043-4

[8] SA. Park, SH. Lee, WD. Kim: Fabrication of porous polycaprolactone/hydroxyapatite (PCL/HA) blend scaffolds using 3D plotting system for bone tissue engineering, Bioprocess Biosyst Eng, Dec 18, 2010, Published online.

DOI: 10.1007/s00449-010-0499-2